S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
These 2 Healthcare Stocks Have Doubled in 2023
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Bed Bath & Beyond Is Circling the Drain
AMD Results Are No Reason To Buy Semiconductors... Yet
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
Institutions are Buying up Procter & Gamble Shares, Should you?
S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
These 2 Healthcare Stocks Have Doubled in 2023
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Bed Bath & Beyond Is Circling the Drain
AMD Results Are No Reason To Buy Semiconductors... Yet
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
Institutions are Buying up Procter & Gamble Shares, Should you?
S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
These 2 Healthcare Stocks Have Doubled in 2023
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Bed Bath & Beyond Is Circling the Drain
AMD Results Are No Reason To Buy Semiconductors... Yet
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
Institutions are Buying up Procter & Gamble Shares, Should you?
S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
These 2 Healthcare Stocks Have Doubled in 2023
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Bed Bath & Beyond Is Circling the Drain
AMD Results Are No Reason To Buy Semiconductors... Yet
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
Institutions are Buying up Procter & Gamble Shares, Should you?
NASDAQ:AFIB

Acutus Medical - AFIB Stock Forecast, Price & News

$1.87
+0.21 (+12.65%)
(As of 02/1/2023 12:00 AM ET)
Add
Compare
Today's Range
$1.66
$1.94
50-Day Range
$0.68
$1.87
52-Week Range
$0.48
$2.49
Volume
339,041 shs
Average Volume
245,269 shs
Market Capitalization
$53.21 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.00

Acutus Medical MarketRank™ Forecast

Analyst Rating
Hold
2.33 Rating Score
Upside/​Downside
7.0% Upside
$2.00 Price Target
Short Interest
Healthy
1.61% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.16mentions of Acutus Medical in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($2.84) to ($2.77) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.73 out of 5 stars

Medical Sector

558th out of 1,053 stocks

Surgical & Medical Instruments Industry

57th out of 105 stocks


AFIB stock logo

About Acutus Medical (NASDAQ:AFIB) Stock

Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

Receive AFIB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acutus Medical and its competitors with MarketBeat's FREE daily newsletter.

AFIB Stock News Headlines

Cash Holders STILL Aren't Taking Steps to Prepare
Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.
Cash Holders STILL Aren't Taking Steps to Prepare
Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.
BTIG Keeps Their Buy Rating on Acutus Medical (AFIB)
Earnings Preview For Acutus Medical
AFIB Acutus Medical, Inc.
See More Headlines
Receive AFIB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acutus Medical and its competitors with MarketBeat's FREE daily newsletter.

AFIB Company Calendar

Last Earnings
11/10/2022
Today
2/02/2023
Next Earnings (Estimated)
3/29/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:AFIB
Employees
291
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$2.00
High Stock Price Forecast
$2.50
Low Stock Price Forecast
$1.50
Forecasted Upside/Downside
+7.0%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

Net Income
$-117,680,000.00
Net Margins
-545.51%
Pretax Margin
-545.51%

Debt

Sales & Book Value

Annual Sales
$15.76 million
Book Value
$3.78 per share

Miscellaneous

Free Float
21,538,000
Market Cap
$53.21 million
Optionable
Not Optionable
Beta
0.65

Key Executives

  • Mr. R. Scott Huennekens CPA (Age 58)
    M.B.A., Exec. Chairman
    Comp: $121k
  • Mr. David Harrison Roman (Age 40)
    CEO, Pres & Director
    Comp: $679.4k
  • Mr. Vincent J. Burgess (Age 57)
    Consultant
    Comp: $583.5k
  • Mr. Takeo Mukai
    VP of Fin. & Accounting and Interim CFO
  • Dr. Graydon E. Beatty (Age 65)
    Chief Technology Officer
  • Dr. Derrick Chou Ph.D.
    Chief Technology Officer
  • Mr. Tom Sohn (Age 47)
    Sr. VP, Gen. Counsel & Sec.
  • Mr. Shibaji Shome Ph.D.
    VP of Marketing
  • Mr. Charlie Piscitello (Age 59)
    Sr. VP & Chief People Officer
  • Mr. Gary W. Doherty (Age 56)
    Sr. VP of Fin.













AFIB Stock - Frequently Asked Questions

Should I buy or sell Acutus Medical stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Acutus Medical in the last twelve months. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" AFIB shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AFIB, but not buy additional shares or sell existing shares.
View AFIB analyst ratings
or view top-rated stocks.

What is Acutus Medical's stock price forecast for 2023?

3 analysts have issued 1-year price targets for Acutus Medical's shares. Their AFIB share price forecasts range from $1.50 to $2.50. On average, they predict the company's share price to reach $2.00 in the next twelve months. This suggests a possible upside of 7.0% from the stock's current price.
View analysts price targets for AFIB
or view top-rated stocks among Wall Street analysts.

How have AFIB shares performed in 2023?

Acutus Medical's stock was trading at $1.15 at the start of the year. Since then, AFIB stock has increased by 62.6% and is now trading at $1.87.
View the best growth stocks for 2023 here
.

When is Acutus Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 29th 2023.
View our AFIB earnings forecast
.

How were Acutus Medical's earnings last quarter?

Acutus Medical, Inc. (NASDAQ:AFIB) announced its quarterly earnings data on Thursday, November, 10th. The company reported ($0.72) EPS for the quarter, beating the consensus estimate of ($0.83) by $0.11. The company earned $3.64 million during the quarter, compared to analyst estimates of $3.52 million. Acutus Medical had a negative net margin of 545.51% and a negative trailing twelve-month return on equity of 100.62%.

What guidance has Acutus Medical issued on next quarter's earnings?

Acutus Medical updated its FY 2022 earnings guidance on Sunday, January, 29th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $16.10 million-$16.30 million, compared to the consensus revenue estimate of $15.70 million.

What other stocks do shareholders of Acutus Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Acutus Medical investors own include Oak Street Health (OSH), Alibaba Group (BABA), Checkmate Pharmaceuticals (CMPI), Salesforce (CRM), Walt Disney (DIS), DocuSign (DOCU), Marvell Technology (MRVL), NVIDIA (NVDA), Tesla (TSLA) and Twilio (TWLO).

When did Acutus Medical IPO?

(AFIB) raised $126 million in an initial public offering (IPO) on Thursday, August 6th 2020. The company issued 7,400,000 shares at $16.00-$18.00 per share. J.P. Morgan, BofA Securities and William Blair acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

What is Acutus Medical's stock symbol?

Acutus Medical trades on the NASDAQ under the ticker symbol "AFIB."

Who are Acutus Medical's major shareholders?

Acutus Medical's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include James F Hinrichs, Orbimed Advisors Llc and R Scott Huennekens.
View institutional ownership trends
.

How do I buy shares of Acutus Medical?

Shares of AFIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Acutus Medical's stock price today?

One share of AFIB stock can currently be purchased for approximately $1.87.

How much money does Acutus Medical make?

Acutus Medical (NASDAQ:AFIB) has a market capitalization of $53.21 million and generates $15.76 million in revenue each year. The company earns $-117,680,000.00 in net income (profit) each year or ($3.10) on an earnings per share basis.

How many employees does Acutus Medical have?

The company employs 291 workers across the globe.

How can I contact Acutus Medical?

Acutus Medical's mailing address is 2210 FARADAY AVE SUITE 100, CARLSBAD CA, 92008. The official website for the company is www.acutusmedical.com. The company can be reached via phone at 442-232-6080, via email at investors@acutusmedical.com, or via fax at 442-232-6081.

This page (NASDAQ:AFIB) was last updated on 2/2/2023 by MarketBeat.com Staff